Cleidson Pádua Alves

Cleidson Pádua Alves

Auto-generated profile, based on publicly available information

Cleidson Pádua Alves

Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Stem Cells
Verified
Journal Article
Closed access
PDF file
CACleidson Pádua Alves
Cleidson Pádua Alves
AFAline Simoneti Fonseca
Aline Simoneti Fonseca
BMBruna Rodrigues Muys
Bruna Rodrigues Muys
RBRafaela Barros e Lima Bueno
Rafaela Barros e Lima Bueno
MBMatheus Carvalho Bürger
Matheus Carvalho Bürger
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr

1 February 2015 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
IDIpsita Dey-Guha
Ipsita Dey-Guha
CACleidson P. Alves
Cleidson P. Alves
AYAlbert C. Yeh
Albert C. Yeh
SASalony
Salony
XSXavier Sole
Xavier Sole
SRSridhar Ramaswamy
Sridhar Ramaswamy
All cancers contain an admixture of rapidly and slowly proliferating cancer cells. This proliferative heterogeneity complicates the diagnosis and treatment of patients with cancer because slow proliferators are hard to eradicate, can be difficult to detect, and may cause disease relapse sometimes years after apparently curative treatment. While clonal selection theory explains the presence and evolution of rapid proliferators within cancer cell populations, the circumstances and molecular details of how slow proliferators are produced is not well understood. Here, a β1-integrin/FAK/mTORC2/AKT1–associated signaling pathway is discovered that can be triggered for rapidly proliferating cancer cells to undergo asymmetric cell division and produce slowly proliferating AKT1low daughter cells. In addition, evidence indicates that the proliferative output of this signaling cascade involves a proteasome-dependent degradation process mediated by the E3 ubiquitin ligase TTC3. These findings reveal that proliferative heterogeneity within cancer cell populations, in part, is produced through a targetable signaling mechanism, with potential implications for understanding cancer progression, dormancy, and therapeutic resistance. Implications: These findings provide a deeper understanding of the proliferative heterogeneity that exists in the tumor environment and highlight the importance of designing future therapies against multiple proliferative contexts. Visual Overview. A proposed mechanism for producing slowly proliferating cancer cells. http://mcr.aacrjournals.org/content/early/2015/01/09/1541-7786.MCR-14-0474/F1.large.jpg. Mol Cancer Res; 13(2); 223–30. ©2015 AACR.

1 January 2012 in Journal of Biotechnology
Verified
Journal Article
Closed access
AGAndrezza N. Gonçalves
Andrezza N. Gonçalves
CMCesar A. Meschiari
Cesar A. Meschiari
WSWilliam G. Stetler-Stevenson
William G. Stetler-Stevenson
MNMaria Cristina Nonato
Maria Cristina Nonato
CACleidson P. Alves
Cleidson P. Alves
RGRaquel Fernanda Gerlach
Raquel Fernanda Gerlach

21 March 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TIT C Izidoro-Toledo
T C Izidoro-Toledo
ABA C Borges
A C Borges
DAD D Araújo
D D Araújo
DMD P S Leitão Mazzi
D P S Leitão Mazzi
FNF O Nascimento
F O Nascimento
EEEnilza Maria Espreafico
Enilza Maria Espreafico
Previous studies proposed that myosin-Va regulates apoptosis by sequestering pro-apoptotic Bmf to the actin cytoskeleton through dynein light chain-2 (DLC2). Adhesion loss or other cytoskeletal perturbations would unleash Bmf, allowing it to bind and inhibit pro-survival Bcl2 proteins. Here, we demonstrated that overexpression of a myosin-Va medial tail fragment (MVaf) harboring the binding site for DLC2 dramatically decreased melanoma cell viability. Morphological and molecular changes, including surface blebbing, mitochondrial outer membrane permeabilization, cytochrome-c and Smac release, as well as caspase-9/-3 activation and DNA fragmentation indicated that melanoma cells died of apoptosis. Immobilized MVaf interacted directly with DLCs, but complexed MVaf/DLCs did not interact with Bmf. Overexpression of DLC2 attenuated MVaf-induced apoptosis. Thus, we suggest that, MVaf induces apoptosis by sequestering DLC2 and DLC1, thereby unleashing the pair of sensitizer and activator BH3-only proteins Bmf and Bim. Murine embryonic fibroblasts (MEFs) lacking Bim and Bmf or Bax and Bak were less sensitive to apoptosis caused by MVaf expression than wild-type MEFs, strengthening the putative role of the intrinsic apoptotic pathway in this response. Finally, MVaf expression attenuated B16-F10 solid tumor growth in mice, suggesting that this peptide may be useful as an apoptosis-inducing tool for basic and translational studies.

1 December 2013 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
CACleidson P. Alves
Cleidson P. Alves
MMMilene H. Moraes
Milene H. Moraes
JSJosane F. Sousa
Josane F. Sousa
CPCarmen Lucia S. Pontes
Carmen Lucia S. Pontes
ARAnelisa Ramão
Anelisa Ramão
EEEnilza Maria Espreafico
Enilza Maria Espreafico

17 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
CJCarlos Alberto Oliveira de Biagi Junior
Carlos Alberto Oliveira de Biagi Junior
SCSarah Santiloni Cury
Sarah Santiloni Cury
CACleidson de Pádua Alves
Cleidson de Pádua Alves
NRNabil Rabhi
Nabil Rabhi
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
MJMiguel Luiz Batista Jr.
Miguel Luiz Batista Jr.
Adipose tissue has been classified based on its morphology and function as white, brown, or beige / brite. It plays an essential role as a regulator of systemic metabolism through paracrine and endocrine signals. Recently, multiple adipocyte subtypes have been revealed using RNA sequencing technology, going beyond simply defined morphology but by their cellular origin, adaptation to metabolic stress, and plasticity. Here, we performed an in-depth analysis of publicly available single-nuclei RNAseq from adipose tissue and utilized a workflow template to characterize adipocyte plasticity, heterogeneity, and secretome profiles. The reanalyzed dataset led to the identification of different subtypes of adipocytes including three subpopulations of thermogenic adipocytes and provided a characterization of distinct transcriptional profiles along the adipocyte trajectory under thermogenic challenges. This study provides a useful resource for further investigations regarding mechanisms related to adipocyte plasticity and trans-differentiation. Highlights: Multidimensional transcriptome analysis at single-nucleus resolution recovers nuclei of cell types in adipose tissue Adaptative thermogenic response results in 3 distinct mature adipose cell types Single-nuclei transcriptomic-based secretome analysis reveals adipose cell-type-specific genes The in vivo trajectory of adipocyte plasticity for thermogenic response reveals sets of trans-differentiation genes Graphic